The main aim of this study is to establish disease-oriented biobank to facilitate research in biology of the lumbar disc degeneration. Diverse biological samples (whole blood, plasma, disc tissue) along with MRI imaging, clinical, socio-demographic and various omics data (e.g. genomic and transcriptomic) will be available for researchers and clinicians for a variety of further multi-omics studies. It will lay the groundwork for the development of early diagnostics of DDD and its personalized treatment. The study is planned to enroll up to 1,100 patients with different grades of lumbar disc degeneration. It is planned to recruit patients within 36 months.
Study Type
OBSERVATIONAL
Enrollment
1,070
Translational, observational study
Priorov National Medical Research Center of Traumatology and Orthopedics
Moscow, Russia
Institute of Cytology and Genetics
Novosibirsk, Russia
Novosibirsk Research Institute of Traumatology and Orthopaedics n.a.Ya.L.Tsivyan
Novosibirsk, Russia
Genotyping
DNA will be extracted from the whole blood samples according to the standard protocol
Time frame: Through 3 years
Phenotype of patients with lumbar disc degeneration
General information about a patient, his medical history and MRI scans of lumbar spine
Time frame: Through 3 years
Total plasma proteins N-glycosylation profiling
The plasma glycans profiling will be performed according to standard protocol
Time frame: Through 3 years
Total RNA profiling
The intraoperative material will be homogenized and total RNA will be extracted and converted to cDNA using Kit for the isolation of total RNA and microRNA from cells and tissues and M-MuLV-RH First Strand cDNA Synthesis Kit respectively. The amount of extracted RNA and its quality will be estimated using Bioanalyzer 2100.
Time frame: Through 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.